Sign inGet started

KHOSLA CHAITAN PHD

Insider CIK 1135139 · PTGX Director · FWBI Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
ENTO Entero Therapeutics, Inc. A Award2024-06-112024-06-1224,889— $024,889SEC↗
FWBI First Wave BioPharma, Inc. A Award deriv2024-03-132024-03-15141— $0141SEC↗
FWBI First Wave BioPharma, Inc. A Award deriv2024-03-132024-03-1552,980— $052,980SEC↗
FWBI First Wave BioPharma, Inc. A Award2024-03-132024-03-15440— $0440SEC↗
PTGX Protagonist Therapeutics, M Exercise deriv2020-08-112020-08-122,499— $07,499SEC↗
PTGX Protagonist Therapeutics, S Sale2020-08-112020-08-122,499$17.19 $43.0K0SEC↗
PTGX Protagonist Therapeutics, M Exercise2020-08-112020-08-122,499$1.89 $4.7K2,499SEC↗
PTGX Protagonist Therapeutics, A Award deriv2020-05-282020-05-2915,000— $015,000SEC↗
PTGX Protagonist Therapeutics, A Award deriv2019-08-152020-04-085,000— $05,000SEC↗
PTGX Protagonist Therapeutics, A Award deriv2019-06-072019-06-1112,000— $012,000SEC↗
PTGX Protagonist Therapeutics, A Award deriv2018-05-292018-06-1212,000— $012,000SEC↗
PTGX Protagonist Therapeutics, A Award deriv2018-05-152019-04-023,000— $03,000SEC↗
PTGX Protagonist Therapeutics, A Award deriv2017-05-252017-05-2612,000— $012,000SEC↗
PTGX Protagonist Therapeutics, A Award deriv2016-09-132016-09-1524,000— $024,000SEC↗
PTGX Protagonist Therapeutics, A Award deriv2016-09-132016-09-285,000— $05,000SEC↗